|
on the internet
Useful Web Sites for Investigating Refractive Surgery
September 2005
viewpoint
By: Paul S. Koch, M.D.
Want Chips With That?
September 2005
at press time
Drug investigators ethics are questioned, and more
September 2005
instrument insider
By: Sina J. Sabet, MD, FACS
The Sabet Safety Net
September 2005
the path to paperless
By: Peter J. Polack, M.D., F.A.C.S.
Choosing the Right Software
September 2005
coding & reimbursement
By: Suzanne L. Corcoran, C.O.E.
Medicare and Presbyopia-Correcting IOLs
September 2005
spotlight on technology & technique
By: Leslie Goldberg, Associate Editor
The Ocular Response Analyzer
September 2005
marketplace
Focus on Microkeratomes
September 2005
stat tracker
A Comprehensive Study of Eye Injuries in the United States
September 2005
Managing Complications in Refractive Surgery
By: Barrie Soloway, M.D.
Two articles focus on strategies for preventing common and uncommon side effects of LASIK.
September 2005
LASIK: Avoiding Dry Eye and Corneal Complications
By: Renee Solomon, M.D.
Patients' complications can be lessened by understanding the ailment and managing corneal issues.
September 2005
Surgical Pearls for the Femtosecond Laser
By: William W. Culbertson, M.D.
How we create successful IntraLase flaps.
September 2005
When Physicians LOSE Malpractice Suits
By: Brian R. Wilson, Esq.
True tales from a plaintiff's attorney.
September 2005
Going Bare?
By: Joseph J. Feltes, J.D.
No insurance could end up costing you more.
September 2005
An Exercise Program For Crystalens Patients
By: Paul S. Koch, M.D.; Jaqueline Hammett
How to use word search games to help crystalens patients.
September 2005
RLE: A Developing Niche With Potential for More?
By: John Parkinson, M.D.
Refractive lens exchange (RLE) is gaining steam and, in some patient populations, taking on LASIK.
September 2005
Epi-LASIK: the Procedure, Pain Management and Patient Results
By: William Trattler, M.D.; Mark Volpicelli, M.D.
Providing a better understanding of epi-LASIK surgery and its aftermath.
September 2005
Incorporating the Verisyse Phakic IOL into Practice
By: Rachel Renshaw, Executive Editor
Patient satisfaction with this IOL is high 1 year after FDA approval.
September 2005
|